undefined
EUTM file information

018773964

PHENO LOCK


October 10, 2022

Trademark Summary

The trademark application PHENO LOCK was filed by Quell Therapeutics Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on November 10, 2022, and it was registered by office on February 17, 2023 without any oppositions.

The application was filed in English (German was selected as the second language).


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemical and biological preparations for use in science and industry
    2. Chemical and biological preparations for non-medical purposes
    3. Preparations for genetically modifying human and animal cells [other than for medical or veterinary purposes]
    4. Reagents for use in the genetic modification of human and animal calls [other than for medical or veterinary purposes]
    5. Human and animal cells and parts thereof for scientific and research purposes
    6. T cells for scientific and research purposes
    7. Regulatory T cells for scientific and research purposes
    8. Preparations of blood or cells extracted from humans and animals for scientific and research purposes
    9. Immunological agents and preparations for non-medical purposes
    10. Chimeric antigen receptors and preparations thereof for scientific and research purposes
    11. Antibody reagents for use in science and industry
    12. Nucleic acids
    13. Nucleic recombinant acids
    14. Synthetic deoxyribonucleic acids
    15. Viral vectors for use in science and industry
    16. Nucleic acid vectors for use in science and industry.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use
    2. Pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes
    3. Preparations for cell therapy
    4. Preparations for gene therapy
    5. Preparations for genetically modifying human and animal cells for diagnostic and medical purposes
    6. Human and animal cells and parts thereof for medical and veterinary purposes
    7. T cells for medical and veterinary purposes
    8. Regulatory T cells for medical and veterinary purposes
    9. Preparations of blood or cells extracted from humans and animals which have been adapted for therapeutic purposes
    10. Pharmaceutical, medical and clinical preparations for use in treatment, amelioration and prophylaxis of diseases, disorders and suppression of the immune system
    11. Immunological agents and preparations for medical purposes
    12. Preparations for therapies to modulate the immune system
    13. Preparations for therapies for autoimmune conditions and immunological disorders
    14. Chimeric antigen receptors and therapeutic preparations thereof
    15. Antibodies
    16. Preparations for therapeutic delivery of nucleic acids
    17. Viral vectors for therapeutic and prophylactic purposes
    18. Nucleic acid vectors for therapeutic and prophylactic purposes
    19. Medical preparations containing viral vectors for therapeutic and prophylactic purposes
    20. Medical preparations containing nucleic acid vectors for therapeutic and prophylactic purposes.
  • The mark was filed in class 40 with following description of goods:
    1. Pharmaceutical manufacturing and processing
    2. Biological, biotechnological and biopharmaceutical manufacturing and processing
    3. Biological tissue, blood, cell and genetic material processing
    4. Viral vector production and manufacture
    5. Gene therapy production and manufacture
    6. Custom manufacture of pharmaceutical and biological formulations and products
    7. Processing and modification of human and animal cells in the custom manufacture of pharmaceutical and biological formulations and products.